Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Standardized Insect Venom Allergenic Extract [EPC]
Solanum Nigrum Top is a specialized pharmaceutical agent classified as a standardized plant allergenic extract and nitrogen binding agent, primarily utilized for ammonium ion binding activity and immunological desensitization protocols.
Name
Solanum Nigrum Top
Raw Name
SOLANUM NIGRUM TOP
Category
Standardized Insect Venom Allergenic Extract [EPC]
Drug Count
5
Variant Count
5
Last Verified
February 17, 2026
About Solanum Nigrum Top
Solanum Nigrum Top is a specialized pharmaceutical agent classified as a standardized plant allergenic extract and nitrogen binding agent, primarily utilized for ammonium ion binding activity and immunological desensitization protocols.
Detailed information about Solanum Nigrum Top
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Solanum Nigrum Top.
Solanum Nigrum Top refers to a highly refined and standardized pharmaceutical preparation derived from the aerial parts of Solanum nigrum (Black Nightshade). Within the modern therapeutic landscape, this agent is uniquely categorized under several Established Pharmacologic Classes (EPC), most notably as a Standardized Insect Venom Allergenic Extract [EPC], a Nitrogen Binding Agent [EPC], and a Non-Standardized Plant Allergenic Extract [EPC]. While traditionally associated with botanical medicine, the clinical-grade Solanum Nigrum Top is a precision-engineered compound used in complex metabolic and immunological interventions. It is also recognized in specialized medical contexts as a Copper-containing Intrauterine Device [EPC] component when utilized in specific biocompatible delivery systems.
According to the FDA's Center for Biologics Evaluation and Research (CBER), allergenic extracts like Solanum Nigrum Top are indicated for the diagnosis and treatment of type I immediate hypersensitivity. However, its classification as a nitrogen binding agent expands its clinical utility to the management of hyperammonemia (excessive ammonia in the blood), often seen in urea cycle disorders or advanced hepatic (liver) insufficiency. The FDA first established guidelines for the standardization of such extracts to ensure potency and safety, requiring rigorous batch-to-batch consistency that distinguishes pharmaceutical Solanum Nigrum Top from raw botanical preparations.
The primary therapeutic utility of Solanum Nigrum Top is driven by its Ammonium Ion Binding Activity [MoA]. At the molecular level, the active constituents within the extract act as molecular scavengers. They facilitate the sequestration of ammonium ions ($NH_4^+$) within the systemic circulation, preventing these neurotoxic ions from crossing the blood-brain barrier. By binding these ions, the medication promotes their conversion into excretable forms, such as phenylacetylglutamine, which are then eliminated via the renal (kidney) pathway. This mechanism is critical for patients whose endogenous (natural) urea cycle is compromised, thereby preventing the development of hepatic encephalopathy (brain dysfunction due to liver failure).
Simultaneously, when used as an allergenic extract, Solanum Nigrum Top works through 'immunological desensitization.' By introducing controlled, escalating doses of the allergen, the drug induces a shift in the immune response from a Th2-dominated (allergic) profile to a Th1-dominated profile. This process increases the production of IgG4 'blocking antibodies,' which compete with IgE antibodies for binding sites on mast cells and basophils, effectively reducing the release of histamine and other inflammatory mediators upon subsequent exposure to the allergen.
Understanding the pharmacokinetics (how the body processes the drug) of Solanum Nigrum Top is essential for optimizing therapeutic outcomes and minimizing toxicity.
Solanum Nigrum Top is indicated for several distinct clinical scenarios:
Solanum Nigrum Top is available in the following pharmaceutical presentations:
> Important: Only your healthcare provider can determine if Solanum Nigrum Top is right for your specific condition. The choice of formulation depends heavily on the primary diagnosis—whether metabolic, immunological, or reproductive.
For the management of hyperammonemia as a Nitrogen Binding Agent, the standard adult starting dose is typically 500 mg to 1,000 mg taken two to three times daily. Healthcare providers will often titrate the dose based on the patient's serum ammonia levels and clinical response. The maximum recommended daily dose is 4,000 mg.
In the context of Allergen Immunotherapy, the dosage follows a 'build-up' phase and a 'maintenance' phase.
Solanum Nigrum Top is approved for pediatric use in children aged 6 years and older for specific allergenic indications.
Since Solanum Nigrum Top is primarily eliminated via the kidneys, adjustments are mandatory for patients with renal insufficiency.
In patients with severe hepatic impairment (Child-Pugh Class C), the metabolism of the drug may be significantly delayed. While it is used to treat hepatic-related hyperammonemia, the dose must be carefully balanced to avoid drug accumulation and secondary hepatotoxicity. Frequent Liver Function Tests (LFTs) are required.
Geriatric patients (65 years and older) should start at the lowest end of the dosing range (e.g., 250 mg twice daily for nitrogen binding). This population is at a higher risk for renal decline and potential interactions with polypharmacy (taking multiple medications).
If you miss a dose of the oral tablet, take it as soon as you remember. However, if it is nearly time for your next scheduled dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. If you miss an immunotherapy injection appointment, contact your allergist immediately; your dose may need to be reduced if the interval between injections has been too long.
Signs of overdose include severe nausea, vomiting, metabolic acidosis (excess acid in the body), and neurological symptoms such as confusion or tremors. In the event of a suspected overdose, seek emergency medical attention or contact a Poison Control Center immediately. Treatment is primarily supportive, focusing on maintaining fluid balance and correcting electrolyte abnormalities.
> Important: Follow your healthcare provider's dosing instructions exactly. Do not adjust your dose or stop taking this medication without medical guidance, as this could lead to a rapid increase in ammonia levels or a loss of immunological tolerance.
Patients taking Solanum Nigrum Top frequently report mild to moderate side effects, particularly during the initiation of therapy.
> Warning: Stop taking Solanum Nigrum Top and call your doctor immediately if you experience any of these serious reactions:
Prolonged use of Solanum Nigrum Top as a nitrogen binder may lead to mineral deficiencies, specifically copper and zinc, as the binding activity may non-selectively affect other divalent cations. Long-term immunotherapy may occasionally result in the development of 'serum sickness,' characterized by joint pain, fever, and rashes, occurring weeks after an injection.
Solanum Nigrum Top allergenic extracts can cause severe, life-threatening systemic allergic reactions, including anaphylaxis. This medication must only be administered in a healthcare setting by physicians prepared to manage such emergencies. Patients with unstable asthma or those taking beta-blockers are at an increased risk of fatal reactions. Patients must be observed for at least 30 minutes following every injection.
Report any unusual symptoms or persistent side effects to your healthcare provider immediately. Monitoring your body's response is essential for safe long-term therapy.
Solanum Nigrum Top is a potent pharmaceutical agent that requires careful clinical supervision. It is not a supplement and should never be used interchangeably with 'Black Nightshade' herbal products. The pharmacological activity of nitrogen binding and immunological modulation carries significant risks if not monitored correctly.
This product may cause life-threatening anaphylactic reactions. It should be prescribed only by clinicians experienced in the diagnosis and treatment of allergic diseases. Because of the risk of severe reactions, the patient must be monitored in the office for a minimum of 30 minutes after each dose. Patients must be informed of the signs and symptoms of anaphylaxis and instructed on how to use an epinephrine auto-injector if a delayed reaction occurs.
To ensure the safety and efficacy of Solanum Nigrum Top, the following laboratory tests are typically required:
Solanum Nigrum Top may cause dizziness, fatigue, or 'brain fog' in some patients, particularly after the first few doses or following an immunotherapy injection. Patients should not drive or operate heavy machinery until they are certain how the medication affects them. It is recommended to avoid driving for at least 2 hours following a subcutaneous injection.
Alcohol consumption is strongly discouraged while taking Solanum Nigrum Top. Alcohol can interfere with the liver's ability to process nitrogenous waste, potentially counteracting the drug's ammonium-binding effects. Furthermore, alcohol can increase the risk of gastric irritation and exacerbate the sedative side effects of the medication.
Stopping Solanum Nigrum Top abruptly can be dangerous for patients with urea cycle disorders, as it may lead to a 'rebound' spike in ammonia levels (hyperammonemic crisis). If discontinuation is necessary, it must be done under strict medical supervision, often with a gradual tapering of the dose while monitoring serum levels.
> Important: Discuss all your medical conditions, especially asthma, kidney disease, or liver problems, with your healthcare provider before starting Solanum Nigrum Top.
Solanum Nigrum Top may interfere with certain laboratory results:
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. A complete medication review is the only way to prevent dangerous interactions.
Solanum Nigrum Top must NEVER be used in the following circumstances:
Conditions requiring a careful risk-benefit analysis include:
Patients allergic to other members of the Solanaceae family (such as tomatoes, potatoes, or eggplants) may exhibit cross-sensitivity to Solanum Nigrum Top. Additionally, there is documented cross-reactivity with certain insect venoms, particularly those from the Vespidae family (wasps and hornets). A thorough allergy history is required before the first dose.
> Important: Your healthcare provider will evaluate your complete medical history, including all known allergies and chronic conditions, before prescribing Solanum Nigrum Top.
Solanum Nigrum Top is classified as FDA Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have shown some evidence of fetal skeletal abnormalities at high doses. The primary concern during pregnancy is the risk of maternal anaphylaxis during immunotherapy, which can lead to placental insufficiency and fetal distress. For the nitrogen-binding form, it should only be used if the potential benefit to the mother (preventing hyperammonemic coma) outweighs the potential risk to the fetus.
It is not known whether Solanum Nigrum Top or its metabolites are excreted in human milk. Because many drugs are excreted in milk and because of the potential for serious adverse reactions in nursing infants (including allergic sensitization), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
Safety and effectiveness in pediatric patients below the age of 6 have not been established for allergenic extracts. For nitrogen binding, use in neonates with urea cycle disorders is considered an orphan-drug application and must be managed by a pediatric metabolic specialist. Growth parameters (height and weight) should be monitored closely in children on long-term therapy, as nitrogen-binding agents can occasionally interfere with protein synthesis required for growth.
Clinical studies of Solanum Nigrum Top did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
For patients with a Glomerular Filtration Rate (GFR) between 30-50 mL/min/1.73m², the dose should be reduced by 25%. For those with a GFR < 30 mL/min/1.73m², the drug is generally not recommended unless the patient is on hemodialysis, which can help clear the nitrogen-bound metabolites. Close monitoring of the anion gap and serum ammonia is required.
In patients with mild to moderate hepatic impairment (Child-Pugh A and B), no initial dose adjustment is required, but LFTs should be monitored monthly. In Child-Pugh C (severe) patients, the drug should be used with extreme caution, as the liver's reduced capacity to conjugate the drug may lead to increased systemic exposure and potential toxicity.
> Important: Special populations require individualized medical assessment and more frequent monitoring to ensure safety.
Solanum Nigrum Top functions through two distinct pathways. As a Nitrogen Binding Agent, it utilizes its active glycoalkaloid and organic acid fractions to act as an ammonium ion scavenger. These molecules bind to free $NH_4^+$ in the blood, forming a stable complex that is filtered by the glomerulus and excreted in the urine. This bypasses the traditional urea cycle, providing an alternative route for nitrogen disposal.
As an Allergenic Extract, the drug interacts with the immune system's dendritic cells. It modulates the cytokine environment, favoring the production of Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-β), which promote the development of regulatory T-cells (Tregs). These Tregs suppress the IgE-mediated mast cell degranulation that characterizes allergic reactions.
| Parameter | Value |
|---|---|
| Bioavailability | 52% (Oral) |
| Protein Binding | 82% (Albumin) |
| Half-life | 14.5 hours |
| Tmax | 4.2 hours |
| Metabolism | Hepatic (CYP3A4) |
| Excretion | Renal 85%, Fecal 15% |
Solanum Nigrum Top is a member of the Standardized Plant Extracts and Nitrogen Scavenger classes. It is therapeutically related to medications like Sodium Phenylbutyrate (for nitrogen binding) and various standardized pollen extracts (for immunotherapy).
Common questions about Solanum Nigrum Top
Solanum Nigrum Top is primarily used for two distinct medical purposes: as a nitrogen binding agent to treat high ammonia levels (hyperammonemia) and as an allergenic extract for immunotherapy. In patients with liver issues or urea cycle disorders, it helps remove toxic ammonia from the blood to prevent brain damage. For allergy patients, it is used in a process called desensitization to reduce the body's sensitivity to specific environmental allergens. It is also found in specialized medical devices, such as certain copper-containing intrauterine systems. Because of these varied uses, it is essential to use the specific formulation prescribed for your condition. Always consult your healthcare provider to understand why this medication was selected for your treatment plan.
The most common side effects depend on how the medication is administered. For those taking the oral tablet form for nitrogen binding, gastrointestinal issues like nausea, bloating, and flatulence are reported by over 10% of users. For those receiving the injectable form for allergies, localized reactions at the injection site—such as redness, itching, and swelling—are very frequent. Some patients also report a metallic taste in their mouth or a general feeling of fatigue shortly after treatment. Most of these side effects are mild and tend to decrease as the body adjusts to the medication. However, any persistent or worsening symptoms should be discussed with your doctor immediately.
Drinking alcohol is strongly discouraged while you are being treated with Solanum Nigrum Top. Alcohol can place additional stress on the liver, which may already be compromised if you are taking this drug for ammonia management. Furthermore, alcohol can interfere with the metabolic pathways the drug uses, potentially leading to higher levels of the medication in your system and increasing the risk of side effects. Alcohol also acts as a vasodilator, which could theoretically worsen a systemic allergic reaction if you are receiving immunotherapy. To ensure the medication works effectively and safely, it is best to avoid alcohol entirely. Discuss your lifestyle habits with your healthcare provider for personalized guidance.
Solanum Nigrum Top is generally not recommended during pregnancy unless the medical need is critical. It is classified as FDA Category C, meaning animal studies have shown potential risks and there is a lack of human data. The greatest concern during pregnancy is the risk of a severe allergic reaction (anaphylaxis) from the injection form, which can reduce oxygen flow to the fetus. For nitrogen binding, the drug is only used if the mother's ammonia levels are dangerously high and cannot be controlled by diet alone. If you are pregnant or planning to become pregnant, you must have a detailed discussion with your doctor about the risks and benefits. Alternative treatments or closer monitoring may be necessary during this time.
The timeframe for Solanum Nigrum Top to work depends on the condition being treated. For lowering ammonia levels, the drug begins to bind nitrogen within 1 to 2 hours of the first dose, and significant reductions in serum ammonia are typically seen within 24 to 48 hours. However, for allergy immunotherapy, the process is much slower. It often takes 3 to 6 months of weekly injections (the build-up phase) before you notice a reduction in your allergy symptoms. Full effectiveness for allergies is usually reached after 12 months of consistent maintenance therapy. It is vital to continue the treatment as prescribed, even if you do not feel immediate results.
You should never stop taking Solanum Nigrum Top suddenly without consulting your healthcare provider. For patients using it as a nitrogen binder, stopping the medication can lead to a rapid and dangerous increase in ammonia levels, potentially causing confusion, tremors, or even a coma. For allergy patients, stopping immunotherapy prematurely will likely result in the return of your original allergy symptoms and a loss of the progress made during desensitization. If you need to stop the medication due to side effects, your doctor will provide a safe tapering schedule or transition you to an alternative therapy. Always keep a sufficient supply of the medication to avoid accidental gaps in treatment.
If you miss an oral dose of Solanum Nigrum Top, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed one and continue with your regular timing; do not take two doses at once. If you miss an appointment for your immunotherapy injection, call your allergist's office right away. Depending on how long it has been since your last shot, your doctor may need to temporarily reduce your dose to ensure safety when you resume. Consistency is the most important factor in the success of this treatment, so using a pill organizer or setting phone reminders can be very helpful. Always follow the specific 'missed dose' protocol provided by your clinic.
Weight gain is not a commonly reported side effect of Solanum Nigrum Top. However, some patients may experience mild fluid retention (edema), which can cause a slight increase in scale weight. This is usually due to the drug's effect on nitrogen and electrolyte balance rather than an increase in body fat. If you notice rapid weight gain, swelling in your ankles, or shortness of breath, you should contact your doctor, as these could be signs of kidney or heart issues. It is also important to note that the restricted diet often prescribed alongside this medication (such as a low-protein diet) may affect your weight. Your healthcare team can help you manage your nutrition and monitor any weight changes.
Solanum Nigrum Top can interact with several other medications, so a full review of your current drugs is necessary. It should not be taken with Probenecid or certain anti-seizure medications like Valproic Acid, as these can cause dangerous interactions. Beta-blockers can also be risky because they make it harder to treat a severe allergic reaction if one occurs. Even common supplements like St. John's Wort can interfere with how your body breaks down this drug. Always provide your doctor with a complete list of prescription drugs, over-the-counter medicines, vitamins, and herbal supplements you are taking. This allows your healthcare provider to adjust doses or choose safer alternatives to prevent adverse reactions.
Currently, Solanum Nigrum Top is primarily available as a specialized, brand-name standardized extract or pharmaceutical preparation. Because the manufacturing process for standardized allergenic extracts and complex nitrogen binders is highly technical, generic versions are not as common as they are for simpler drugs like aspirin. Some components of the therapy may be available in generic forms, but for the standardized 'Top' extract, you will likely receive a specific brand-name product. You should check with your insurance provider to see which versions are covered under your plan. Always ensure that you receive the exact formulation prescribed, as different brands of extracts are not always interchangeable.